Latest News and Press Releases

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "CDK9 Inhibitor - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. The "Cyclin-Dependent Kinase 9 (CDK9) Inhibitor...

Dublin, March 07, 2025 (GLOBE NEWSWIRE) -- The "Brutons Tyrosine Kinase Btk Inhibitors Market" report has been added to ResearchAndMarkets.com's offering.The Bruton's tyrosine kinase (BTK)...

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2025" drug pipelines has been added to ResearchAndMarkets.com's offering.The "Janus Kinase (JAK)...

Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "Thymidine Kinase 2 Deficiency - Market Insight, Epidemiology, and Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. ...

GEn1E Lifesciences today announced the publication of a landmark study in the prestigious Journal of Pharmacology and Experimental Therapeutics (JPET)

Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The latest insights into the...

Dublin, June 18, 2024 (GLOBE NEWSWIRE) -- The "Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The detailed report furnishes...

Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Global PIM Kinase Targeted Therapies Market Opportunity & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering....

Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Checkpoint Kinase Inhibitors - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. As the global healthcare...

Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Cyclin-Dependent Kinase 9 (CDK9) Inhibitor - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's...